LabID-base/OpenAlex-Afillation huggingface dataset:
Scientific update from the Global NLPHL One Working Group (GLOW)
Year: 2025
Type: article
Topic: Hematopoietic Stem Cell Transplantation
Authors and affiliations:
raw_author_name: M Palese
raw_affiliation_strings: University of Rochester Medical Center, Division of Pediatric Hematology/Oncology, Department of Pediatrics, Rochester, USA
University of Rochester Medical Center, Wilmot Cancer Institute, Rochester, USA
raw_author_name: R H Advani
raw_affiliation_strings: Stanford University, Blood and Marrow Transplant Program, Stanford Cancer Center, Stanford, USA
raw_author_name: S Birz
raw_affiliation_strings: HiQ Analytics LLC, Chicago, USA
raw_author_name: G P Collins
raw_affiliation_strings: Churchill Hospital, Oxford Cancer and Haematology Centre, Oxford, UK
raw_author_name: R T Hoppe
raw_affiliation_strings: Stanford University, Department of Radiation Oncology, Stanford, USA
raw_author_name: K M Kelly
raw_affiliation_strings: Roswell Park Comprehensive Cancer Center, Department of Pediatric Oncology, Buffalo, USA
University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Department of Pediatrics, Buffalo, USA
raw_author_name: M S Binkley
raw_affiliation_strings: Stanford University, Department of Radiation Oncology, Stanford, USA
raw_author_name: J E Flerlage
raw_affiliation_strings: University of Rochester Medical Center, Division of Pediatric Hematology/Oncology, Department of Pediatrics, Rochester, USA
University of Rochester Medical Center, Wilmot Cancer Institute, Rochester, USA
Serum Soluble Immune Factor Levels in Treated Pediatric Hodgkin Lymphoma Patients
Year: 2025
Type: article
Topic: Lymphoma Diagnosis and Treatment
Authors and affiliations:
raw_author_name: V K Singh
raw_affiliation_strings: Justus-Liebig. University Giessen, Pediatric Hematology, Oncology & Immunodeficiencies, Giessen, Germany
raw_author_name: T N Goetzenich
raw_affiliation_strings: Justus-Liebig. University Giessen, Pediatric Hematology, Oncology & Immunodeficiencies, Giessen, Germany
raw_author_name: B M Arneth
raw_affiliation_strings: Justus-Liebig-University, Giessen, Germany, Institut für Laboratoriumsmedizin und Pathobiochemie, Molekulare Diagnostik, Giessen, Germany
raw_author_name: M Braun
raw_affiliation_strings: Justus-Liebig. University Giessen, Pediatric Hematology, Oncology & Immunodeficiencies, Giessen, Germany
raw_author_name: D Körholz
raw_affiliation_strings: Justus-Liebig. University Giessen, Pediatric Hematology, Oncology & Immunodeficiencies, Giessen, Germany
raw_author_name: C Mauz-Körholz
raw_affiliation_strings: Justus-Liebig. University Giessen, Pediatric Hematology, Oncology & Immunodeficiencies, Giessen, Germany
Martin Luther-University Halle-Wittenberg, Medical Faculty, Halle, Germany
raw_author_name: M Rohde
raw_affiliation_strings: Justus-Liebig. University Giessen, Pediatric Hematology, Oncology & Immunodeficiencies, Giessen, Germany
Genetic lesions in nodular lymphocyte-predominant Hodgkin lymphoma and T cell/histiocyte-rich large B-cell lymphoma identified by whole genome sequencing
Year: 2025
Type: article
Topic: Lymphoma Diagnosis and Treatment
Authors and affiliations:
raw_author_name: T Rausch
raw_affiliation_strings: EMBL, Genecore, Heidelberg, Germany
raw_author_name: H Schäfer
raw_affiliation_strings: University Hospital Essen, Pathology, Essen, Germany
raw_author_name: J Bein
raw_affiliation_strings: Goethe University Frankfurt, Frankfurt am Main, Germany
raw_author_name: F Mölder
raw_affiliation_strings: University Hospital Essen, Pathology, Essen, Germany
raw_author_name: L K Beeck
raw_affiliation_strings: University Hospital Essen, Institute of Cell Biology (Cancer Research), Essen, Germany
raw_author_name: B Kölsch
raw_affiliation_strings: University Hospital Essen, Pathology, Essen, Germany
raw_author_name: S Borchert
raw_affiliation_strings: University Hospital Essen, Pathology, Essen, Germany
raw_author_name: V Benes
raw_affiliation_strings: EMBL, Genecore, Heidelberg, Germany
raw_author_name: T Halbsguth
raw_affiliation_strings: Goethe University Frankfurt, Frankfurt am Main, Germany
raw_author_name: U Brunnberg
raw_affiliation_strings: Goethe University Frankfurt, Frankfurt am Main, Germany
raw_author_name: T Oellerich
raw_affiliation_strings: Goethe University Frankfurt, Frankfurt am Main, Germany
raw_author_name: T Tousseyn
raw_affiliation_strings: KU Leuven, Pathology, Leuven, Belgium
raw_author_name: M Ponzoni
raw_affiliation_strings: Scientific Institute San Raffaele, Milan, Italy
raw_author_name: J Köster
raw_affiliation_strings: University Hospital Essen, IKIM, Essen, Germany
raw_author_name: M-L Hansmann
raw_affiliation_strings: Goethe University Frankfurt, Frankfurt am Main, Germany
raw_author_name: R Küppers
raw_affiliation_strings: University Hospital Essen, Institute of Cell Biology (Cancer Research), Essen, Germany
raw_author_name: S Hartmann
raw_affiliation_strings: University Hospital Essen, Pathology, Essen, Germany
Epigenetic Age Acceleration Before and After Treatment for Young Adult Hodgkin Lymphoma: A Pilot Study from URCC10055
Year: 2025
Type: article
Topic: Acute Lymphoblastic Leukemia research
Authors and affiliations:
raw_author_name: A M Williams
raw_affiliation_strings: University of Rochester School of Medicine and Dentistry, Rochester, USA
raw_author_name: K Breit
raw_affiliation_strings: University of Rochester School of Medicine and Dentistry, Rochester, USA
raw_author_name: M Sohn
raw_affiliation_strings: University of Rochester School of Medicine and Dentistry, Rochester, USA
raw_author_name: J Flerlage
raw_affiliation_strings: University of Rochester School of Medicine and Dentistry, Rochester, USA
raw_author_name: C Casulo
raw_affiliation_strings: University of Rochester School of Medicine and Dentistry, Rochester, USA
raw_author_name: S Yao
raw_affiliation_strings: Roswell Park Cancer Institute, Buffalo, USA
raw_author_name: B Esparaz
raw_affiliation_strings: Heartland Cancer Research NCORP, Decatur, USA
raw_author_name: C Jorgensen
raw_affiliation_strings: NCOPR of the Carolina&apos;s-Prisma Health, Greenville, USA
raw_author_name: J Misleh
raw_affiliation_strings: Delaware Christiana Care NCORP, Newark, USA
raw_author_name: J Friedberg
raw_affiliation_strings: University of Rochester School of Medicine and Dentistry, Rochester, USA
raw_author_name: M Janelsins
raw_affiliation_strings: University of Rochester School of Medicine and Dentistry, Rochester, USA
Real World Experience of Brentuximab Vedotin and Immune Checkpoint Inhibitor in Pediatric Refractory and Relapsed Classical Hodgkin Lymphoma: A Retrospective Study from Two Centers in Taiwan
Year: 2025
Type: article
Topic: Lymphoma Diagnosis and Treatment
Authors and affiliations:
raw_author_name: M-H Hou
raw_affiliation_strings: Department of Pediatric Hematology and Oncology, Taipei Veteran General Hospital, Taipei city, Taiwan
raw_author_name: H-J Yen
raw_affiliation_strings: Department of Pediatric Hematology and Oncology, Taipei Veteran General Hospital, Taipei city, Taiwan
raw_author_name: S-H Chen
raw_affiliation_strings: Division of Pediatric Hematology/Oncology, Linkou Chang Gung Memorial Hospital, Taoyuan city, Taiwan
Response-Adapted Omission of Radiotherapy in Pediatric Patients with Intermediate- and High-Risk Hodgkin Lymphoma Treated per EuroNet-PHL-C1: A Single Institution Analysis of Outcomes and Patterns of Failure
Year: 2025
Type: article
Topic: Lymphoma Diagnosis and Treatment
Authors and affiliations:
raw_author_name: K Shliakhtsitsava
raw_affiliation_strings: University of Texas Southwestern, Pediatric Hematology and Oncology, Dallas, USA
raw_author_name: M Jackson
raw_affiliation_strings: University of Texas Southwestern, Dallas, USA
raw_author_name: A Berry
raw_affiliation_strings: Children&apos;s Hospital of Philadelphia, Pediatric Hematology and Oncology, Philadelphia, USA
raw_author_name: S Montalvo
raw_affiliation_strings: Cook Children&apos;s Hospital, Dallas Fort Worth, USA
raw_author_name: T Dan
raw_affiliation_strings: Harold C Simmons Comprehensive Cancer Center, Radiation Oncology, Dallas, USA
University of Texas Southwestern, Dallas, USA
raw_author_name: R A Herring
raw_affiliation_strings: Children&apos;s Health, Pediatric Hematology and Oncology, Dallas, USA
raw_author_name: K Cederberg
raw_affiliation_strings: University of Texas Southwestern, Pediatric Radiology, Dallas, USA
raw_author_name: T Sloan
raw_affiliation_strings: University of Texas Southwestern, Pediatric Hematology and Oncology, Dallas, USA
raw_author_name: M Pacheco
raw_affiliation_strings: St.Luke&apos;s Children&apos;s Cancer Institute, Pediatric Hematology and Oncology, Boise, USA
raw_author_name: C Greer
raw_affiliation_strings: Cook Children&apos;s Hospital, Dallas Fort Worth, USA
raw_author_name: K Kumar
raw_affiliation_strings: Harold C Simmons Comprehensive Cancer Center, Radiation Oncology, Dallas, USA
University of Texas Southwestern, Dallas, USA
Post-transplant lymphoproliferative disease type Hodgkin lymphoma: limiting toxicity while maximizing efficacy with personalized treatment approach in a rare entity. Experience in a case series.
Year: 2025
Type: article
Topic: Viral-associated cancers and disorders
Authors and affiliations:
raw_author_name: V Brindicci
raw_affiliation_strings: University of Bari, School of Specialization in Pediatrics, BARI, Italy
raw_author_name: P Muggeo
raw_affiliation_strings: University Hospital of Policlinico of Bari, Pediatric Hematology and Oncology, BARI, Italy
raw_author_name: E Facchini
raw_affiliation_strings: IRCCS S. Orsola Malpighi, Pediatric Hematology and Oncology, BOLOGNA, Italy
raw_author_name: M Grassi
raw_affiliation_strings: University Hospital of Policlinico of Bari, Pediatric Hematology and Oncology, BARI, Italy
raw_author_name: R Daniele
raw_affiliation_strings: University Hospital of Policlinico of Bari, Pediatric Hematology and Oncology, BARI, Italy
raw_author_name: R Angarano
raw_affiliation_strings: University Hospital of Policlinico of Bari, Pediatric Hematology and Oncology, BARI, Italy
raw_author_name: N Santoro
raw_affiliation_strings: University Hospital of Policlinico of Bari, Pediatric Hematology and Oncology, BARI, Italy
raw_author_name: M Mascarin
raw_affiliation_strings: CRO IRCCS, AYA Oncology and Pediatric Radiotherapy Unit, AVIANO, Italy
Predicted Breast Cancer Risk after Mediastinal Radiotherapy for Pediatric Hodgkin Lymphoma: Analysis of a Multi-Institutional Children’s Oncology Group Trial
Year: 2025
Type: article
Topic: Lymphoma Diagnosis and Treatment
Authors and affiliations:
raw_author_name: S A Milgrom
raw_affiliation_strings: University of Colorado, Radiation Oncology, Aurora, USA
raw_author_name: H Paganetti
raw_affiliation_strings: Massachusetts General Hospital, Radiation Oncology, Boston, USA
raw_author_name: H Dama
raw_affiliation_strings: Princess Margaret Cancer Centre and University of Toronto, Radiation Oncology, Toronto, Canada
raw_author_name: L Renfro
raw_affiliation_strings: Children&apos;s Oncology Group, Biostatistics, Monrovia, USA
University of Southern California, Biostatistics, Los Angeles, USA
raw_author_name: Y Wu
raw_affiliation_strings: Children&apos;s Oncology Groups, Biostatistics, Gainesville, USA
raw_author_name: I Meyer
raw_affiliation_strings: Massachusetts General Hospital, Radiation Oncology, Boston, USA
raw_author_name: M Jeeva
raw_affiliation_strings: Princess Margaret Cancer Centre and University of Toronto, Radiation Oncology, Toronto, Canada
raw_author_name: S K Parsons
raw_affiliation_strings: Tufts Medical Center, Hematology/Oncology and Institute for Clinical Research and Health Policy Studies, Boston, USA
raw_author_name: A Punnett
raw_affiliation_strings: SickKids Hospital, Hematology/Oncology, Toronto, Canada
raw_author_name: A-M Charpentier
raw_affiliation_strings: Centre hospitalier de l&apos;Universite de Montreal, Radiation Oncology, Montreal, Canada
raw_author_name: A C Lo
raw_affiliation_strings: British Columbia Cancer, Radiation Oncology, Vancouver, Canada
raw_author_name: R Mailhot Vega
raw_affiliation_strings: University of Florida, Radiation Oncology, Jacksonville, USA
raw_author_name: F Keller
raw_affiliation_strings: Emory University, Aflac Cancer and Blood Disorders Center, Atlanta, USA
raw_author_name: K M Kelly
raw_affiliation_strings: Roswell Park Comprehensive Cancer Center and University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Pediatric Oncology, Buffalo, USA
raw_author_name: B S Hoppe
raw_affiliation_strings: Mayo Clinic Florida, Radiation Oncology, Jacksonville, USA
raw_author_name: S M Castellino
raw_affiliation_strings: Emory University, Aflac Cancer and Blood Disorders Center, Atlanta, USA
raw_author_name: D Hodgson
raw_affiliation_strings: Princess Margaret Cancer Centre and University of Toronto, Radiation Oncology, Toronto, Canada
Validation of a gene signature based on tumor microenvironment composition for risk stratification of pediatric patients with classical Hodgkin lymphoma.Update.
Year: 2025
Type: article
Topic: Lymphoma Diagnosis and Treatment
Authors and affiliations:
raw_author_name: R Angarano
raw_affiliation_strings: University Hospital of Policlinico Bari, Pediatric Hematology and Oncology, BARI, Italy
raw_author_name: P Muggeo
raw_affiliation_strings: University Hospital of Policlinico Bari, Pediatric Hematology and Oncology, BARI, Italy
raw_author_name: M Grassi
raw_affiliation_strings: University Hospital of Policlinico Bari, Pediatric Hematology and Oncology, BARI, Italy
raw_author_name: R Daniele
raw_affiliation_strings: University Hospital of Policlinico Bari, Pediatric Hematology and Oncology, BARI, Italy
raw_author_name: M Loiotine
raw_affiliation_strings: University Hospital of Policlinico Bari, Pediatric Hematology and Oncology, BARI, Italy
raw_author_name: R Martino
raw_affiliation_strings: University of Bari &quot;Aldo Moro&quot;, School of Specialization in Pediatrics, BARI, Italy
raw_author_name: G Gargano
raw_affiliation_strings: IRCCS Istituto Tumori &apos;Giovanni Paolo II&apos;, Hematology and Cell Therapy Unit, BARI, Italy
raw_author_name: G Ingravallo
raw_affiliation_strings: University of Bari &quot;Aldo Moro&quot;, Section of Molecular Pathology, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), BARI, Italy
raw_author_name: E Bellitti
raw_affiliation_strings: University of Bari &quot;Aldo Moro&quot;, Section of Molecular Pathology, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), BARI, Italy
raw_author_name: G Opinto
raw_affiliation_strings: Bonomo Hospital, Clinical Pathology and Microbiology Unit, ANDRIA, Italy
raw_author_name: M C Vegliante
raw_affiliation_strings: IRCCS Istituto Tumori &apos;Giovanni Paolo II&apos;, Hematology and Cell Therapy Unit, BARI, Italy
raw_author_name: S Ciavarella
raw_affiliation_strings: IRCCS Istituto Tumori &apos;Giovanni Paolo II&apos;, Hematology and Cell Therapy Unit, BARI, Italy
raw_author_name: S A Pappagallo
raw_affiliation_strings: IRCCS Istituto Tumori &apos;Giovanni Paolo II&apos;, Hematology and Cell Therapy Unit, BARI, Italy
raw_author_name: A Guarini
raw_affiliation_strings: IRCCS Istituto Tumori &apos;Giovanni Paolo II&apos;, Hematology and Cell Therapy Unit, BARI, Italy
raw_author_name: N Santoro
raw_affiliation_strings: University Hospital of Policlinico Bari, Pediatric Hematology and Oncology, BARI, Italy
Survival By Race/Ethnicity in Children and Adolescents/Young Adults with Relapsed/Refractory Hodgkin Lymphoma: A Pooled Analysis of Children&amp;apos;s Oncology Group Trials
Year: 2025
Type: article
Topic: Lymphoma Diagnosis and Treatment
Authors and affiliations:
raw_author_name: M B Heneghan
raw_affiliation_strings: University of Utah/Huntsman Cancer Institute, Department of Pediatrics, Division of Pediatric Hematology/Oncology, Salt Lake City, USA
raw_author_name: L Renfro
raw_affiliation_strings: University of Southern California and Children’s Oncology Group, Los Angeles, USA
raw_author_name: Y Wu
raw_affiliation_strings: Children’s Oncology Group Statistics & Data Center, Gainesville, USA
raw_author_name: T Trippett
raw_affiliation_strings: Memorial Sloan Kettering Cancer Center, New York, USA
raw_author_name: T Horton
raw_affiliation_strings: Texas Children&apos;s Cancer Center, Baylor College of Medicine, Houston, USA
raw_author_name: F Keller
raw_affiliation_strings: Aflac Cancer and Blood Disorders Center, Emory University School of Medicine / Children&apos;s Healthcare of Atlanta, Atlanta, USA
raw_author_name: C Forlenza
raw_affiliation_strings: Memorial Sloan Kettering Cancer Center, New York, USA
raw_author_name: K Kelly
raw_affiliation_strings: Roswell Park Comprehensive Cancer Center, University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Department of Pediatric Oncology, Buffalo, USA
raw_author_name: P Cole
raw_affiliation_strings: Robert Wood Johnson Medical School, Rutgers Cancer Institute of New Jersey, Division of Pediatric Hematology/Oncology, New Brunswick, USA
raw_author_name: S Castellino
raw_affiliation_strings: Aflac Cancer and Blood Disorders Center, Emory University School of Medicine / Children&apos;s Healthcare of Atlanta, Atlanta, USA
raw_author_name: J Kahn
raw_affiliation_strings: Columbia University Irving Medical Center, Department of Pediatrics, New York, USA
Twenty-Year Review of Paediatric Classical Hodgkin Lymphoma in Hong Kong: Treatment Evolution and Outcomes
Year: 2025
Type: article
Topic: Lymphoma Diagnosis and Treatment
Authors and affiliations:
raw_author_name: O K Fan
raw_affiliation_strings: Hong Kong Children&apos;s Hospital, Department of Paediatrics and Adolescent Medicine, Hong Kong, Hong Kong
raw_author_name: AK S Chiang
raw_affiliation_strings: The University of Hong Kong, Department of Paediatrics and Adolescent Medicine, Hong Kong, Hong Kong
raw_author_name: M K Shing
raw_affiliation_strings: Hong Kong Children&apos;s Hospital, Department of Paediatrics and Adolescent Medicine, Hong Kong, Hong Kong
raw_author_name: GK S Lam
raw_affiliation_strings: Hong Kong Children&apos;s Hospital, Department of Paediatrics and Adolescent Medicine, Hong Kong, Hong Kong
Health-Related Quality of Life in Individuals Diagnosed with Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL): An Initial Report from the Global NLPHL One Working Group
Year: 2025
Type: article
Topic: Lymphoma Diagnosis and Treatment
Authors and affiliations:
raw_author_name: A M Jones
raw_affiliation_strings: St. Jude Children&apos;s Research Hospital, Department of Psychology and Biobehavioral Sciences, Memphis, USA
raw_author_name: V M Crabtree
raw_affiliation_strings: St. Jude Children&apos;s Research Hospital, Department of Psychology and Biobehavioral Sciences, Memphis, USA
raw_author_name: M Rees
raw_affiliation_strings: St. Jude Children&apos;s Research Hospital, Department of Oncology, Memphis, USA
raw_author_name: Y Zheng
raw_affiliation_strings: St. Jude Children&apos;s Research Hospital, Department of Biostatistics, Memphis, USA
raw_author_name: Y Zhou
raw_affiliation_strings: St. Jude Children&apos;s Research Hospital, Department of Biostatistics, Memphis, USA
raw_author_name: J Rogers Blake
raw_affiliation_strings: St. Jude Children&apos;s Research Hospital, Cancer Center, Memphis, USA
raw_author_name: J Flerlage
raw_affiliation_strings: University of Rochester Medical Center, Department of Pediatrics, Hematology and Oncology, Rochester, USA
raw_author_name: C Forlenza
raw_affiliation_strings: Memorial Sloan Kettering, Cancer Center, New York, USA
raw_author_name: A Major
raw_affiliation_strings: University of Colorado School of Medicine, Division of Hematology, Aurora, USA
Race, ethnicity, and insurance inequities in Hodgkin lymphoma (HL) treatment and survivorship care in the US: A study in progress
Year: 2025
Type: article
Topic: Economic and Financial Impacts of Cancer
Authors and affiliations:
raw_author_name: R Mailhot Vega
raw_affiliation_strings: University of Florida College of Medicine, Radiation Oncology, Jacksonville, USA
raw_author_name: C Fisher
raw_affiliation_strings: University of Florida College of Medicine, Health Outcomes and Biomedical Informatics, Gainesville, USA
raw_author_name: A Crisp
raw_affiliation_strings: University of Florida College of Medicine Jacksonville, Jacksonville, Florida, Center for Data Solutions, Jacksonville, USA
raw_author_name: M D Mullis
raw_affiliation_strings: University of Florida College of Medicine, Gainesville, USA
raw_author_name: R Cacchio
raw_affiliation_strings: University of Florida Health Proton Therapy Institute, Jacksonville, USA
raw_author_name: A Gardner
raw_affiliation_strings: University of Florida Health Proton Therapy Institute, Jacksonville, USA
raw_author_name: J Causer
raw_affiliation_strings: University of Florida Health Proton Therapy Institute, Jacksonville, USA
raw_author_name: E Michel
raw_affiliation_strings: University of Florida Health Proton Therapy Institute, Jacksonville, USA
raw_author_name: D Weinbrenner
raw_affiliation_strings: University of Florida College of Medicine, Health Outcomes and Biomedical Informatics, Gainesville, USA
raw_author_name: R Hayes
raw_affiliation_strings: Independent Patient Advocate, Birmingham, USA
raw_author_name: E Lynch
raw_affiliation_strings: UF Health, Patient Advocate, Gainesville, USA
raw_author_name: T Hernandez
raw_affiliation_strings: Leukemia & Lymphoma Society, Patient Advocate, Atlanta, USA
raw_author_name: A Parker
raw_affiliation_strings: University of Florida College of Medicine Jacksonville, Research Affairs, Jacksonville, USA
raw_author_name: Y Guo
raw_affiliation_strings: University of Florida College of Medicine, Health Outcomes and Biomedical Informatics, Gainesville, USA
raw_author_name: S Castellino
raw_affiliation_strings: Emory School of Medicine, Pediatrics, Atlanta, USA
raw_author_name: E Mobley
raw_affiliation_strings: University of Florida College of Medicine Jacksonville, Surgery, Jacksonville, USA